Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Psychopharmacology of Psilocybin in Cancer Patients

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Heffter Research Institute
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00465595
First received: April 23, 2007
Last updated: October 10, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)